JPRN-UMIN000003076招募中2 期
Phase II study to evaluate the safety and the efficacy of CBD (Bortezomib, Cyclophosphamide, Dexamethasone) regimen for the patients with relapsed and/or refractory multiple myeloma - Phase II study to evaluate the safety and the efficacy of CBD (Bortezomib, Cyclophosphamide, Dexamethasone) regimen for the patients with relapsed and/or refractory multiple myeloma
ara Hospital Kinki University School Of Medicine0 个研究点目标入组 20 人开始时间: 2010年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •performance status:3 and 4(excluding PS3 by bone pain and fracture)
研究者
相似试验
进行中（未招募）
1 期
Study of a combination therapy in patients with Waldenstrom Macroglobulinemia and active disease not previously treatedEUCTR2013-002388-25-ITAzienda Ospedaliera Ospedali Riuniti Marche Nord40
招募中
2 期
GCDR trialJPRN-jRCTs051230119Kitano Masayuki38
招募中
2 期
Evaluation of the efficacy of bioadhesive barrier-forming oral liquid gel (Episil) for prevention of oral mucositisJPRN-jRCTs062220023Takano HIdeyuki50
已完成
不适用
Intensive blood glucose control for chronic obstructive pulmonary disease (COPD) patients on acute medical wardsAcute exacerbation of chronic obstructive pulmonary disease (AECOPD)RespiratoryOther chronic obstructive pulmonary diseaseISRCTN42412334St George's, University of London (UK)20
尚未招募
2 期
Study to examine the efficacy and safety of Awa Suzuka extracted ingredientsHealthy subjects with serum triglyceride levels in the borderline rangeJPRN-UMIN000052759Tokushima University Graduate School40